Literature DB >> 34158098

Correction to: Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.

Na Zhu1,2, Emilia M Swietlik3, Carrie L Welch1, Michael W Pauciulo4,5, Nicholas W Morrell3,6,7,8, Yufeng Shen2,9, Stefan Gräf3,6,10, William C Nichols4,5, Wendy K Chung11,12,13, Jacob J Hagen1,2, Xueya Zhou1,2, Yicheng Guo2, Johannes Karten14, Divya Pandya3, Tobias Tilly3, Katie A Lutz4, Jennifer M Martin3,6, Carmen M Treacy3, Erika B Rosenzweig1, Usha Krishnan1, Anna W Coleman4, Claudia Gonzaga-Jauregui15, Allan Lawrie16, Richard C Trembath17, Martin R Wilkins18.   

Abstract

Entities:  

Year:  2021        PMID: 34158098      PMCID: PMC8220777          DOI: 10.1186/s13073-021-00915-w

Source DB:  PubMed          Journal:  Genome Med        ISSN: 1756-994X            Impact factor:   11.117


× No keyword cloud information.
Correction to: Genome Med 13, 80 (2021) https://doi.org/10.1186/s13073-021-00891-1 It was highlighted that the original article [1] contained an error in the name of Claudia Gonzaga-Jauregui. It was incorrectly captured as Gonzaga-Juaregui. The original article has been updated.
  1 in total

1.  Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH.

Authors:  Na Zhu; Emilia M Swietlik; Carrie L Welch; Michael W Pauciulo; Nicholas W Morrell; Yufeng Shen; Stefan Gräf; William C Nichols; Wendy K Chung; Jacob J Hagen; Xueya Zhou; Yicheng Guo; Johannes Karten; Divya Pandya; Tobias Tilly; Katie A Lutz; Jennifer M Martin; Carmen M Treacy; Erika B Rosenzweig; Usha Krishnan; Anna W Coleman; Claudia Gonzaga-Jauregui; Allan Lawrie; Richard C Trembath; Martin R Wilkins
Journal:  Genome Med       Date:  2021-05-10       Impact factor: 15.266

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.